Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome

C.M. Chu, Y.Y. Leung, J.Y.H. Hui, I.F.N. Hung, V.L. Chan, W.S. Leung, K.I. Law, C.S. Chan, K.S. Chan, K.Y. Yuen
European Respiratory Journal 2004 23: 802-804; DOI: 10.1183/09031936.04.00096404
C.M. Chu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y.Y. Leung
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.Y.H. Hui
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I.F.N. Hung
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V.L. Chan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W.S. Leung
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K.I. Law
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C.S. Chan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K.S. Chan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K.Y. Yuen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Spontaneous pneumomediastinum (SP) unrelated to assisted ventilation is a newly recognised complication of severe acute respiratory syndrome (SARS). The objective of the present study was to examine the incidence, risk factors and the outcomes of SP in a cohort of SARS victims from a community outbreak.

Data were retrieved from a prospectively collected database of virologically confirmed SARS patients. One hundred and twelve cases were analysable, with 13 patients developing SP (11.6%) at a mean±sd of 19.6±4.6 days from symptom onset.

Peak lactate dehydrogenase level was associated with the development of SP. SP was associated with increased intubation and a trend towards death. Drainage was required in five cases. For patients who survived, the SP and/or the associated pneumothoraces took a median of 28 days (interquartile range: 15–45 days) to resolve completely.

In conclusion, spontaneous pneumomediastinum appeared to be a frequent complication of severe acute respiratory syndrome. Further research is needed to investigate its pathogenesis.

  • Complication
  • coronavirus
  • pneumomediastinum
  • pneumothorax
  • severe acute respiratory syndrome

Severe acute respiratory syndrome (SARS) has been documented to be caused by a novel coronavirus (SARS-CoV) 1–3, which satisfied the Koch's postulations for causation 4, 5. At the time of writing, the numbers of probable SARS cases has reached 8,422 globally 6. Two previous studies have noted the occurrence of spontaneous pneumomediastinum (SP) occasionally in patients with SARS, unrelated to assisted ventilation 7, 8. However, SP in SARS has not been systematically studied. In the present study the incidence, risk factors and the implications of the development of SP in SARS sufferers were examined.

Methods

The present study examined SP in SARS patients by retrospective analysis of a prospectively collected SARS database. Patients included in the study were consecutive SARS patients admitted to the United Christian Hospital (Hong Kong, SAR, China) during a community outbreak from March 24 to April 28, 2003. Patients met a modified WHO definition of SARS, which included fever (≥38°C), cough or shortness of breath, new pulmonary infiltrates on radiological examination, in the absence of an alternative diagnosis, together with virological documentation of SARS-CoV infection (paired serology and/or positive RT-PCR for SARS-CoV from clinical specimens). All patients were treated with a standard protocol of broad spectrum antibiotics, ribavirin and a tailing regimen of corticosteroids 9. The clinical, haematological, biochemical, radiological and virological findings were prospectively entered into a preset database, according to previous publications 1, 7.

Chest radiographs were taken at intervals of 1 to 3 days, depending on clinical need. SP was defined as the presence of gas in the mediastinum, occurring before assisted ventilation. For equivocal cases, high resolution computed tomography (HRCT) of the thorax would be utilised to detect this complication. All chest radiographs and HRCT were interpreted by thoracic radiologists.

Results were expressed as mean±sd unless otherwise specified. Univariate analyses of potential factors associated with the occurrence of SP were performed with the unpaired t-test, Mann-Whitney U-test or Fisher's exact test where appropriate. A two-tailed p-value of <0.05 was considered statistically significant.

Results

There were 123 virologically confirmed SARS patients admitted to hospital during the study period. Altogether, there were 24 patients with pneumomediastinum: 13 had SP and 11 developed pneumomediastinum with or without pneumothorax after the commencement of assisted ventilation. The baseline characteristics were not significantly different between those with SP and those with ventilator-associated barotraumas (VAB) (table 1⇓). However, the cumulative dose of methylprednisolone received by the SP group prior to the onset of pneumomediastinum was significantly lower than that received by the VAB group (median: 2.0 versus 3.0 g, respectively, p=0.003).

View this table:
  • View inline
  • View popup
Table 1—

Comparisons of initial clinical, radiological and laboratory features between severe acute respiratory syndrome (SARS) patients with spontaneous pneumomediastinum (SP) and ventilator-associated barotraumas (VAB)

Eleven cases of VAB were excluded from further analysis. This left 112 cases for analysis, including 13 cases complicated by SP. The mean age of the 112 cases was 38.8±12.7 yrs. There were 46 males (41.1%) and 66 females (58.9%). The initial chest radiographs appeared normal in 28 (25%) patients, who had HRCT findings compatible with SARS. Multilobar involvement was evident on presentation in 21 (18.8%) cases.

Thirteen patients developed SP (11.6%) during the course of SARS, at a mean of 19.6±4.6 days from symptom onset. Of these 13 cases, one had concomitant subcutaneous emphysema, three had simultaneous spontaneous bilateral pneumothoraces, and two had subsequent progression into subcutaneous emphysema and bilateral pneumothoraces. One patient had pneumomediastinum, bilateral pneumothoraces and subcutaneous emphysema (fig. 1⇓). Bilateral tube thoracostomies were necessary in the five cases complicated by bilateral pneumothoraces, of whom one case received chemical pleurodesis; the rest of the SP was managed conservatively. No patient in this series had isolated pneumothorax and all pneumothoraces occurred concomitantly with, or were preceded by, SP.

Fig. 1.—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.—

High-resolution computed tomography (HRCT) thorax of a patient with severe acute respiratory syndrome (SARS) complicated by spontaneous pneumomediastinum, subcutaneous emphysema and rims of bilateral pneumothoraces.

Univariate analysis showed that only peak serum lactate dehydrogenase (LDH) was associated with the development of SP (p=0.001). Other factors, including viral load in the nasopharynx, cumulative dose of corticosteroids, initial radiographical findings and other laboratory parameters were not associated with the development of SP (table 2⇓).

View this table:
  • View inline
  • View popup
Table 2—

Comparisons of potential risk factors and the outcomes of severe acute respiratory syndrome (SARS) patients with and without spontaneous pneumomediastinum (SP)

Of the 13 patients with SP, five were intubated and two of the intubated patients died; two additional patients with SP died without intubation on surrogates' requests, giving a total of four deaths in SP patients. Patients who developed SP had a statistically higher chance of intubation (p=0.015) and showed more of a trend towards death (p=0.057) (table 1⇑). For patients who survived, the SP and/or the associated pneumothoraces took a median of 28 days (interquartile range: 15–45 days) to resolve completely.

Discussion

SP developed in 11.6% of the present study SARS cohort at 19.6±4.6 days from symptom onset. High peak LDH level was associated with its development. Development of SP was associated with significant intubation rate and mortality. In survivors, resolution of SP was slow.

Pneumomediastinum is the presence of extra-alveolar air in the mediastinum. Free air leaks from ruptured alveoli, dissecting along the bronchovascular sheaths towards the mediastinum 10. The incidence of SP was reported to be one in 32,896 in the general population 11. In immunocompetent hosts with pulmonary infections, air leak as a complication is uncommon, but it has been reported in staphylococcal pneumonia 12 and fungal pneumonia 13. It has also been reported to complicate interstitial pneumonitis secondary to systemic lupus erythematosus 14 and bronchiolitis obliterans organising pneumonia 15. In HIV infection, SP is reported in association with Pneumocystis carinii pneumonia in 9.5% and with tuberculosis in 6.8% of cases 16. SP is also reported to complicate cytomegalovirus pneumonitis in patients with haematological malignancies 17 and idiopathic pneumonia syndrome after bone marrow transplantation 18.

It was interesting to note that isolated pneumothorax, without a preceding or concomitant pneumomediastinum, was not observed in the current series of patients. One possible explanation is that the current study examined the patients regularly by chest radiographs and/or HRCT. This might have given the authors an opportunity to witness a sequence of events that took place in these severely lung-damaged patients. The current authors postulate that alveolar rupture may occur in SARS as a result of severe diffuse alveolar damage 19 and cause interstitial emphysema. Air may then dissect along the bronchovascular sheaths into the mediastinum to manifest as SP initially, which may further progress to pneumothoraces and subcutaneous emphysema in some patients.

VAB in the current study was, by definition, not spontaneous and, therefore, could not be classified as SP. However, their clinical, laboratory and radiological features did not seem to be fundamentally different from those of SP. The higher dose of methylprednisolone received in patients with VAB versus those with SP was probably an indicator of the need for more intensive treatment in sicker patients. It is possible that both SP and VAP in SARS share similar pathogenic mechanisms, although mechanical ventilation may further aggravate barotraumas and air leak.

High peak LDH level, which might signify cellular damage, was associated with the development of SP. In contrast, viral load was not related to the development of SP, suggesting processes other than viral-induced cytolysis might be important in the pathogenesis of alveolar damage (e.g. immunopathological damage). In this connection, it is interesting to note that the onset of SP (mean: 19 days) occurs after the phase of viral replication (day 10), at a time when immunopathological damage is thought to be important 7.

In conclusion, spontaneous pneumomediastinum appeared to be a characteristic and frequent complication of severe acute respiratory syndrome. It portends a poor outcome. Further research is needed to investigate the pathogenesis of spontaneous pneumomediastinum in severe acute respiratory syndrome.

  • Received August 22, 2003.
  • Accepted January 22, 2004.
  • © ERS Journals Ltd

References

  1. ↵
    Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:1319–1325.
    OpenUrlCrossRefPubMedWeb of Science
  2. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953–1966.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967–1976.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    Fouchier RA, Kuiken T, Schutten M, et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 2003;423:240.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    Kuiken T, Fouchier RA, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003;362:263–270.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    World Health Organization. Summary table of SARS cases by country, 1 November 2002–7 August 2003. www.who.int/csr/sars/country/en/country2003_08_15.pdf. Date last updated: August 15, 2003. Date last accessed: August 19, 2003.
  7. ↵
    Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361:1767–1772.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    Hui JYH, Cho DHY, Yang MKW, et al. Severe acute respiratory syndrome: spectrum of high resolution CT findings and temporal progression of the disease. Am J Roentgen 2003;181:1525–1538.
    OpenUrlPubMedWeb of Science
  9. ↵
    So LK, Lau AC, Yam LY, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003;361:1615–1617.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    Macklin CC. Transport of air along sheaths of pulmonic blood vessels from alveoli to mediastinum: clinical implications. Arch Intern Med 1939;64:913–926.
    OpenUrlCrossRefWeb of Science
  11. ↵
    Bodey GP. Medical mediastinal emphysema. Ann Intern Med 1961;54:46–56.
    OpenUrlCrossRefWeb of Science
  12. ↵
    Yates SP, Morcos SK. Delayed tension pneumothorax complicating staphylococcal pneumonia. Postgrad Med J 1988;64:796–798.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Ödev K, Çaliskan Ü, Emlik D, et al. Pneumomediastinum and pneumopericardium due to intracavitary aspergilloma: an unusual complication of fungal pneumonia. Pediatr Radiol 2002;32:143–145.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    Masuda A, Tsushima T, Shizume K, et al. Recurrent pneumothoraces and mediastinal emphysema in systemic lupus erythematosus. J Rheumatol 1990;17:544–548.
    OpenUrlPubMedWeb of Science
  15. ↵
    Kofteridis D, Bouros DE, Vamvakas LN, et al. Pneumothorax complicating fatal bronchiolitis obliterans organizing pneumonia. Respiration 1999;66:266–268.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    Tumbarello M, Tacconelli E, Pirronti T, et al. Pneumothorax in HIV-infected patients: role of Pneumocystis carinii pneumonia and pulmonary tuberculosis. Eur Respir J 1997;10:1332–1335.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Olliff JFC, Williams MP. Radiological appearances of cytomegalovirus infection. Clin Radiol 1989;40:463–467.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Kudoh T, Suzuki N, Oda T, et al. Pneumomediastinum, subcutaneous emphysema, and pulmonary fibrosis in patient with idiopathic pneumonia syndrome after bone marrow transplantation. Pediatr Hematol Oncol 2000;17:113–117.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    Nicholls JM, Poon LL, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003;361:1773–1778.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 23 Issue 6 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome
C.M. Chu, Y.Y. Leung, J.Y.H. Hui, I.F.N. Hung, V.L. Chan, W.S. Leung, K.I. Law, C.S. Chan, K.S. Chan, K.Y. Yuen
European Respiratory Journal Jun 2004, 23 (6) 802-804; DOI: 10.1183/09031936.04.00096404

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome
C.M. Chu, Y.Y. Leung, J.Y.H. Hui, I.F.N. Hung, V.L. Chan, W.S. Leung, K.I. Law, C.S. Chan, K.S. Chan, K.Y. Yuen
European Respiratory Journal Jun 2004, 23 (6) 802-804; DOI: 10.1183/09031936.04.00096404
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society